跳至主要内容
临床试验/ITMCTR2024000005
ITMCTR2024000005招募中1 期

Scientific and technological innovation project of China Academy of Chinese Medicine Sciences

Guang'anmen Hospital of China Academy of Chinese Medicine Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • standard constrain:
  • (1) Age 18-75 years old;
  • (2) In line with the ultrasound diagnosis of thyroid nodules, including solid, cystic-solid, cystic nodules, and inflammatory nodules, and the long diameter of thyroid nodules = 0.5 cm and < 5.0 cm;
  • (3)Less than 4 bilobular thyroid nodules;
  • (4) Fine needle aspiration biopsy (FNAB) cytopathology of high-risk nodules suggests non-malignant lesions;
  • (5) Meet the diagnostic criteria of TCM syndrome of gall disease with liver stagnation and spleen deficiency syndrome;
  • (6) Those who signed the informed consent.

排除标准

  • (1) Those who have childbearing needs during pregnancy, lactation and within the past 12 months;
  • (2) Nodule with clustered or coarse calcification on the edge or inside of the nodule;
  • (3) Those who are allergic to traditional Chinese medicine or its components;
  • (4)Patients with serious primary diseases or mental illness such as liver, kidney and hematopoietic system;
  • (5) Patients who have been diagnosed with thyroid cancer or combined with other malignant tumors;
  • (6) Patients with obvious local compression symptoms of the thyroid gland, hoarseness, dysphagia, etc. who meet the indications for surgical treatment and need surgical treatment;
  • (7) Anyone who is judged by the investigator to be unsuitable to participate in this trial;
  • (8) Those who have other concomitant medication related to thyroid function and nodule treatment.

研究者

发起方
Guang'anmen Hospital of China Academy of Chinese Medicine Sciences

相似试验